Opin vísindi

The global NAFLD policy review and preparedness index : Are countries ready to address this silent public health challenge?

Skoða venjulega færslu

dc.contributor.author NAFLD policy review collaborators
dc.date.accessioned 2022-08-24T01:02:48Z
dc.date.available 2022-08-24T01:02:48Z
dc.date.issued 2022-04-01
dc.identifier.citation NAFLD policy review collaborators 2022 , ' The global NAFLD policy review and preparedness index : Are countries ready to address this silent public health challenge? ' , Journal of Hepatology , vol. 76 , no. 4 , pp. 771-780 . https://doi.org/10.1016/j.jhep.2021.10.025
dc.identifier.issn 0168-8278
dc.identifier.other 45175229
dc.identifier.other 590e8479-0ead-4770-9964-ee3c35763762
dc.identifier.other 85122443139
dc.identifier.other 34895743
dc.identifier.other unpaywall: 10.1016/j.jhep.2021.10.025
dc.identifier.uri https://hdl.handle.net/20.500.11815/3336
dc.description The data collection and analysis were funded by the EASL International Liver Foundation with support from, Intercept, Bristol-Myers-Squibb Company, Genfit, and MSD. Data collection for the original European data was funded by the EASL International Liver Foundation supported by Gilead Sciences Europe Ltd., Allergan Pharmaceutical International Ltd., Bristol-Myers-Squibb Company, Pfizer Inc., and Resoundant Inc. Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
dc.description.abstract BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. METHODS: We collected data from 102 countries, accounting for 86% of the world population, on NAFLD policies, guidelines, civil society engagement, clinical management, and epidemiologic data. A preparedness index was developed by coding questions into 6 domains (policies, guidelines, civil awareness, epidemiology and data, NAFLD detection, and NAFLD care management) and categorising the responses as high, medium, and low; a multiple correspondence analysis was then applied. RESULTS: The highest scoring countries were India (42.7) and the United Kingdom (40.0), with 32 countries (31%) scoring zero out of 100. For 5 of the domains a minority of countries were categorised as high-level while the majority were categorised as low-level. No country had a national or sub-national strategy for NAFLD and <2% of the different strategies for related conditions included any mention of NAFLD. National NAFLD clinical guidelines were present in only 32 countries. CONCLUSIONS: Although NAFLD is a pressing public health problem, no country was found to be well prepared to address it. There is a pressing need for strategies to address NAFLD at national and global levels. LAY SUMMARY: Around a third of the countries scored a zero on the NAFLD policy preparedness index, with no country scoring over 50/100. Although NAFLD is a pressing public health problem, a comprehensive public health response is lacking in all 102 countries. Policies and strategies to address NAFLD at the national and global levels are urgently needed.
dc.format.extent 10
dc.format.extent 2231163
dc.format.extent 771-780
dc.language.iso en
dc.relation.ispartofseries Journal of Hepatology; 76(4)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Adult
dc.subject Global Health
dc.subject Humans
dc.subject Non-alcoholic Fatty Liver Disease/complications
dc.subject Obesity/complications
dc.subject Policy
dc.subject Public Health
dc.title The global NAFLD policy review and preparedness index : Are countries ready to address this silent public health challenge?
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/systematicreview
dc.description.version Peer reviewed
dc.identifier.doi 10.1016/j.jhep.2021.10.025
dc.relation.url http://www.scopus.com/inward/record.url?scp=85122443139&partnerID=8YFLogxK
dc.contributor.department Office of Division of Clinical Services I
dc.contributor.department Faculty of Medicine


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu